EPO Patents = 1

Trademarks = 3

Forward Citations = 6

Loading Chart...

3 inventors (with patents filed for the assignee):

Lianhong Xu (7 out of 48 patents)

Zhi Hong (3 out of 3 patents)

Robert G Strickley (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 12760058 - Prodrugs of neuroactive steroids (2026-10-13),

2. 12390484 - Adenosine derivative and pharmaceutical composition comprising the same (2025-08-19),

3. 12370208 - Adenosine derivative and pharmaceutical composition comprising the same (2025-07-29),

4. 12370200 - Pharmaceutical composition containing brexanolone, ganaxolone, or zuranolone, and use thereof (2025-07-29),

5. 12257264 - Combination therapy for HIV with adenosine derivative and capsid inhibitors (2025-03-25),

6. 11890297 - Combination therapy for HIV with adenosine derivative and capsid inhibitors (2024-02-06),

7. 11793827 - Adenosine derivative and pharmaceutical composition comprising the same (2023-10-24),

Company Overview

Brii Biosciences, Inc. is a biopharmaceutical company focused on developing innovative therapies for infectious diseases and other serious conditions. The company leverages advanced science and technology to address unmet medical needs, particularly in the areas of viral infections and immune-mediated diseases. With a commitment to improving patient outcomes, Brii Biosciences aims to bring transformative treatments to market through strategic partnerships and a robust pipeline of drug candidates.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#99 in Durham, NC

#857 in North Carolina

#39,907 in US

Durham, NC, United States of America

Brii Biosciences, Inc.

Forward Citations = 6

3 inventors:

Lianhong Xu (7 out of 48 patents)

Zhi Hong (3 out of 3 patents)

Robert G Strickley (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Brii Biosciences, Inc.. Retrieved from https://idiyas.com/company/brii-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]